会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Semisynthetic macrolide antibiotics of the azalide series
    • 半合成大环内酯类抗生素的azalide系列
    • US07342000B2
    • 2008-03-11
    • US10538376
    • 2003-12-10
    • Nedjeljko KujundzicMirjana Bukvic KrajacicKarmen Brajsa
    • Nedjeljko KujundzicMirjana Bukvic KrajacicKarmen Brajsa
    • A61K31/70C07H17/08
    • C07H17/00
    • The invention relates to N″-substituted 9a-N-(N′-carbamoyl-γ-aminopropyl), 9a-N-(N′-thiocarbamoyl-γ-aminopropyl), 9a-N-[N′-β-cyanoethyl)-N′-carbamoyl-γ-aminopropyl] and 9a-N-[N′-β-cyanoethyl)-N′-thiocarbamoyl-γ-am inopropyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithromycin A and 5-O-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerithronolide A, novel semi-synthetic macrolide antibiotics of the azalide series, of the general formula 1, wherein R represents H or cladinosyl moiety, R1 represents H or β-cyanoethyl moiety, R2 represents isopropyl, 1-naphtyl, 2-naphtyl, benzyl, 2-(trifluoromethyl)phenyl, 3-phenylpropyl, β-phenylethyl, ethoxycarbonyl-methyl, 1-(1-naphtyl)ethyl, 3,4,5-trimethoxyphenyl and 2,4-dichlorophenyl group, and X represents O and S, and their acceptable addition salts thereof with inorganic or organic acids, to the process for preparation of their pharmaceutical compositions as well as the use their compositions in the treatment of bacterial infections.
    • 本发明涉及N“ - 取代的9a-N-(N'-氨基甲酰基-γ-氨基丙基),9a-N-(N'-硫代氨基甲酰基-γ-氨基丙基),9a-N- [N'-β-氰基乙基 )-N'-氨基甲酰基-γ-氨基丙基]和9a-脱氧-9-二氢-9a-氮杂-9a的9a-N- [N'-β-氰基乙基] -N'-硫代氨基甲酰基-γ-氨基丙基]衍生物 高锰霉素A和5-O-脱雄氨基-9-脱氧-9-二氢-9a-氮杂-9a-高丝氨酸新一烯内酯A是通式1的氮杂环丁烷系新型半合成大环内酯类抗生素,其中R表示H或克棱糖基 部分,R 1表示H或β-氰乙基部分,R 2表示异丙基,1-萘基,2-萘基,苄基,2-(三氟甲基)苯基,3- 苯基丙基,β-苯基乙基,乙氧基羰基 - 甲基,1-(1-萘基)乙基,3,4,5-三甲氧基苯基和2,4-二氯苯基,X表示O和S及其可接受的加成盐与无机或 有机酸,制备其药物组合物的方法以及使用它们的组成 在治疗细菌感染。